-
Jan 19 |
Diagnostics World News | Cancer tries its hardest not to be found. Seeking to better understand the early tumor micro-environment may prove to be a powerful harbinger of early cancer development. In our quest for early cancer detection, we should look more closely at the complex and potentially detectable changes in the micro-environment surrounding the tumor.
More
-
Jan 15 |
Diagnostics World News I Princeton University spin-off launches AI COVID screening tool, new antibody test helps select donor blood samples for therapeutic use, concerns raised over UK’s rollout of rapid asymptomatic testing, and Wuhan study finds symptoms linger for many. Plus: FDA grants EUA for high-volume antigen test and asymptomatic testing, new simplified COVID-19 testing method, and nanomaterial-based biosensing platform detects COVID-19 antibodies in seconds.
More
-
Jan 12 |
Diagnostics World News | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, focusing heavily on a rosy outlook for clinical genomics.
More
-
Jan 12 |
Diagnostics World News | Valencell today announced that its calibration-free, cuffless blood pressure (BP) technology for wearables is now able to be used in devices worn on the finger and wrist including smartwatches, fitness bands, patches and pulse oximeter finger clips.
More
-
Jan 11 |
Diagnostics World News | Energy-generating bacteria, only in recent years leveraged to power biobatteries, have now been deployed for paper-based biosensing of antibiotic effectiveness. The innovative twist here is a high-throughput antimicrobial susceptibility testing device that eliminates the need for lab culturing and provides actionable results within five hours.
More
-
Jan 08 |
Diagnostics World News I New technology has the potential for at-home immunity monitoring, novel COVID-19 test delivers results in under five minutes, Spectrum Solutions to provide saliva collection device for UK population weekly testing. Plus: Phillips, BioIntelliSense, University of Colorado receive award to validate BioSticker wearable sensor to detect early COVID-19 symptoms.
More
-
Jan 07 |
Diagnostics World News | Within the Diagnostics World vendor community, leaders have been working hard to synthesize what 2020 brought us and apply those learnings to 2021. Here are the full trends and predictions including pathogen surveillance, AMR, telehealth and home diagnostics, machine learning-based triage, omics for diagnostics, and supply chain reliability.
More
-
Jan 06 |
Diagnostics World News | An all-in-one metagenomics test developed by University of California San Francisco (UCSF) scientists could transform the way infectious diseases are diagnosed at the point of care, irrespective of the sample type. The same technology is being adapted as a means to simultaneously detect SARS-CoV-2 and track down drivers of COVID-19 outbreaks at the community level.
More
-
Jan 04 |
Diagnostics World News | Updates from Ibex Medical Analytics and Paige on AI-assisted breast cancer diagnoses, using vocal biomarkers to diagnose pulmonary hypertension, whole genome sequencing in diagnoses, and more.
More
-
Dec 29 |
Diagnostics World News | By March, the whole world was faced with a massive diagnostics problem, and companies everywhere pivoted to focus on methods for diagnosing SARS-CoV-2 infections quickly, accurately, and with a test that could scale. But COVID-19 diagnoses weren’t the year’s only developments. We also covered the growing trends in medical monitoring, organ-on-a-chip models, the regulatory environment for laboratory-developed tests and much more.
More
-
Sep 25 |
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
More
-
Sep 24 |
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
More
-
Sep 24 |
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
More
-
Sep 17 |
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
More
-
Sep 12 |
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
More
-
Sep 12 |
CAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithms
More
-
Sep 12 |
PRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8
More
-
Sep 11 |
ROYAL OAK, MI, UNITED STATES - Sep 11, 2019 - OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22
More
View more articles